VJOncology is committed to improving our service to you

ASCO 2019 | Treatment-related bone loss

VJOncology is committed to improving our service to you

Silke Gillessen

Silke Gillessen, MD, of The Christie NHS Foundation Trust, Manchester, UK, discusses the importance of bone loss in both prostate and breast cancer and how the use of bone-targeted agents can be assessed at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter